ey0020.3-7 | Advances in Clinical Practice | ESPEYB20
W Zhou
, JG van Rooij
, DM van de Laarschot
, Z Zervou
, H Bruggenwirth
, NM Appelman-Dijkstra
, PR Ebeling
, S Demirdas
, AJ Verkerk
, MC Zillikens
In Brief: Prolonged bisphosphonate treatment is associated with atypical femoral fractures (AFF). However, AFFs also occur in bisphosphonate-naïve patients, so bisphosphonate is not a prerequisite for AFF. This study found a higher yield of (likely) pathogenic variants in AFF patients with a clinical suspicion of monogenic bone disorder, stressing the importance of careful clinical evaluation of patients who present with this condition.Commentary: A...